Katie Price says her son, Harvey Price, will begin taking Mounjaro, a weight-loss drug, to help improve his health and quality of life. She also says he has reached a level of concern regarding his body measurements, prompting the decision.
The outlets report that the trigger is Harvey’s BMI moving into the obese range. The Mirror adds that the decision comes after an Ibiza trip, while The Independent focuses more on Katie Price’s update and the stated goal of supporting Harvey’s wellbeing. Both accounts describe Katie Price making the announcement publicly and linking the medication plan to Harvey’s weight-management needs.
While the core details are consistent—Harvey will start Mounjaro and the move is tied to his BMI and health—there are differences in emphasis, with one outlet highlighting the location/context of a recent trip and the other concentrating on the health framing and expected outcome.
